News Medical on MSN2d
Grifols receives grant for early Parkinson's disease biomarker discovery
Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...
The Corner1d
Michael J. Fox Foundation donates Grifols $21 million to research new diagnostic tools for Parkinson’s disease
The Catalan blood products company has received a $21 million grant from the Michael J. Fox Foundation (MJFF) for Parkinson's ...
FierceBiotech4d
Grifols garners $21M grant from Michael J. Fox Foundation to hunt for early Parkinson's disease biomarkers
Spanish pharma Grifols is leveraging its massive collection ... “The hope is to accelerate and ultimately develop new diagnostics and disease-modifying therapeutics that could mitigate or ...
TMCnet3d
Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson's Disease
The unique plasma assets serve as the foundation of the Chronos-PD program, driving advanced research at Grifols subsidiary Alkahest, which is leading the initiative given its specialization in the ...
CNN4y
Grifols, S.A. Sponsored ADR Class B
Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes ...